Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.thechemopharmalaboratoriesltd.com | |
Market Cap | 4.25 Cr. | |
Enterprise Value(EV) | -1.80 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 6.17 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 4.60 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 38.26 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 79.85 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 0.35 | Calculated using Price: 28.34 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.15 Cr. | 1,500,000 Shares |
FaceValue | 10 | |
About Chemo-Pharma Laboratories Ltd. | ||
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues. |
1 Day |
|
|
1 Week |
|
-5.03% |
1 Month |
|
-19.14% |
3 Month |
|
-16.27% |
6 Month |
|
-29.07% |
1 Year |
|
-11.98% |
2 Year |
|
+18.91% |
5 Year |
|
-3.90% |
10 Year |
|
+57.22% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 5.61 | 4.15 | 60.99 | 1.00 | 2.02 | 3.94 | 2.30 | 4.97 | 0.41 | |
Return on Capital Employed (%) | 7.52 | 5.96 | 68.41 | 7.54 | 2.50 | 4.69 | 2.86 | 3.24 | 0.74 | |
Return on Assets (%) | 5.20 | 3.90 | 57.64 | 0.96 | 2.00 | 3.88 | 2.27 | 4.99 | 0.42 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 5 | 5 | 5 | 10 | 10 | 10 | 11 | 11 | 12 | 12 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Curr. Liab. | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 6 | 6 | 11 | 10 | 10 | 11 | 11 | 11 | 11 | |
Non Curr. Assets | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 0 | 5 | 5 | |
Curr. Assets | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 11 | 6 | 6 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 6 | 6 | 11 | 10 | 10 | 11 | 11 | 11 | 11 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | |||||||||||
Other Income | 1 | 0 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Income | 1 | 0 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Expenditure | 0 | 0 | 0 | 0 | -1 | 0 | 0 | -1 | -1 | 0 | |
PBIDT | 0 | 0 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | |
Interest | 0 | ||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | ||||||
Taxation | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | |
Adjusted EPS | 2 | 1 | 31 | 1 | 1 | 3 | 2 | 4 | 0 | 6 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 6 | -2 | -5 | 5 | 0 | 0 | -1 | |
Cash Fr. Inv. | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | |
Cash Fr. Finan. | -1 | 1 | 2 | -2 | 0 | ||||||
Net Change | 0 | 0 | 0 | 6 | 1 | -5 | 6 | 1 | -1 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 7 | 8 | 3 | 9 | 2 | 1 | 1 |
Wed, 04 Oct 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 for the Quarter Ended September 30 2023. |
Fri, 29 Sep 2023
Closure of Trading Window Intimation of Trading Window Closure |
Tue, 26 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report VOTING RESULTS AND CONSOLIDATED SCRUTINIZERS REPORT OF THE 81ST ANNUAL GENERAL MEETING AS PER REGULATION 44 OF SEBI (LODR) REGULATIONS 2015 |
Tue, 03 Oct 2023 |
|
|
|
|
|